Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: May 22, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, regulation-fd
TL;DR
Shuttle Pharma filed a routine 8-K, no major news.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on May 22, 2024, to report on Regulation FD disclosures and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Shuttle Pharmaceuticals is adhering to its reporting obligations with the SEC, providing routine updates on its corporate activities.
Risk Assessment
Risk Level: low — The filing is a standard current report with no disclosed material events or financial changes.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- May 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and financial statements, as indicated by the 'ITEM INFORMATION' section.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 22, 2024.
What is the exact name of the registrant?
The exact name of the registrant is Shuttle Pharmaceuticals Holdings, Inc.
In which state was Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. was incorporated in Delaware.
What is the address of the principal executive offices?
The address of the principal executive offices is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
Filing Stats: 982 words · 4 min read · ~3 pages · Grade level 12.7 · Accepted 2024-05-22 16:15:20
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 10KB
- 0001493152-24-021015.txt ( ) — 231KB
- shph-20240522.xsd (EX-101.SCH) — 3KB
- shph-20240522_lab.xml (EX-101.LAB) — 33KB
- shph-20240522_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: May 22, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer